| Groups |
Parameters |
Control group |
Diabetic group |
Diabetic group with nifedipine |
| Resting |
27.10±6.02 |
110.15±13.30 |
59.65± 7.583 |
| t. test |
|
22.292 |
16.77 |
| P. Value |
|
P < 0.05 |
P < 0.05 |
| Peak 1 (n M) in the presence of (1 mM) external calcium |
428.650 ±106.173 |
456.950 ±114.466 |
448.500 ±103.977 |
| t. test |
|
-0.722 |
1.101 |
| P. Value |
|
P > 0.475 |
P > 0.285 |
| Phase 2 in the presence of external calcium |
290.750 ±31.595 |
874.100 ±111.098 |
600.550 ±145.055 |
| t. test |
|
2.586 |
9.018 |
| P. Value |
|
P < 0.05 |
P < 0.05 |
| Peak 1 in the absence of external calcium |
252.750 ±40.804 |
258.050 ±42.297 |
254.200 ±43.534 |
| t. test |
|
- 0.403 |
1.980 |
| P. Value |
|
P 0.689 |
P 0.062 |
| Phase 2 in the absence of external calcium |
72.550 ±12.626 |
162.450 ±23.302 |
161.500 ±22.441 |
| t. test |
|
15.170 |
0.903 |
| P. Value |
|
P < 0.05 |
P > 0.378 |
